Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC

Small-cell lung cancer (SCLC) is a highly proliferative, invasive lung cancer with poor prognosis. Chemotherapy is still the standard first-line treatment for SCLC, but many patients relapse due to chemoresistance. Along with advances in immunology, it is essential to investigate potential indicator...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Meng-Yu, Zeng, Yue-Can, Zhao, Xi-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240612/
https://www.ncbi.nlm.nih.gov/pubmed/35784467
http://dx.doi.org/10.3389/fcell.2022.893490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240612/
https://www.ncbi.nlm.nih.gov/pubmed/35784467
http://dx.doi.org/10.3389/fcell.2022.893490

Ejemplares similares